Genetic medicines aim straight for the heart - Nature Biotechnology

Norge Nyheter Nyheter

Genetic medicines aim straight for the heart - Nature Biotechnology
Norge Siste Nytt,Norge Overskrifter
  • 📰 NatureBiotech
  • ⏱ Reading Time:
  • 30 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 15%
  • Publisher: 63%

Genetic medicines aim straight for the heart

, a firm founded by Christine Seidman and her husband Jonathan Seidman and later acquired by Bristol Myers Squibb, it works by decreasing the elevated contractility that arises from excessive cross-bridge formation between actin and myosin, the proteins responsible for generating the force that gives rise to heart contractions. Cytokinetics is in phase 3 in obstructive HCM with another oral myosin inhibitor, aficamten.

Tenaya Therapeutics is several years behind Rocket Pharma but is about to move its lead gene therapy program, TN-201, into a phase 1b trial in patients with HCM due to mutations in thegene, which encodes myosin-binding protein C3. The protein is involved in the organization and function of sarcomeres, the basic contractile units of cardiac muscle.

Olson is a co-founder of Tenaya, but rights to his more recent gene editing work in cardiovascular disease have yet to be assigned. Olson’s group developed both adenine base editing and prime editing approaches to correct pathogenic

Vi har oppsummert denne nyheten slik at du kan lese den raskt. Er du interessert i nyhetene kan du lese hele teksten her. Les mer:

NatureBiotech /  🏆 231. in US

Norge Siste Nytt, Norge Overskrifter

Similar News:Du kan også lese nyheter som ligner på denne som vi har samlet inn fra andre nyhetskilder.

Data sharing in the age of deep learning - Nature BiotechnologyData sharing in the age of deep learning - Nature BiotechnologyData sharing in the age of deep learning How can we protect personal information and the integrity of artificial intelligence models when sharing data?
Les mer »

Quantitative analysis of tRNA abundance and modifications by nanopore RNA sequencing - Nature BiotechnologyQuantitative analysis of tRNA abundance and modifications by nanopore RNA sequencing - Nature BiotechnologytRNA abundance and chemical modifications are measured simultaneously with nanopores.
Les mer »

Xenotransplantation: how close are we? - Nature BiotechnologyXenotransplantation: how close are we? - Nature BiotechnologyXenotransplantation: how close are we? A group of experts reflects on what was learned from the first human transplants of genetically engineered pig organs and what the future of xenotransplantation may hold
Les mer »

This Promising Bill Would Flush Period Sales Tax for Menstruating TexansThis Promising Bill Would Flush Period Sales Tax for Menstruating TexansICYMI: Texas may soon catch up with other states when it comes to taking sales tax off of some essential items.
Les mer »



Render Time: 2025-03-04 20:00:34